Your session is about to expire
← Back to Search
Simultaneous UroLift™ and HoLEP for Enlarged Prostate
N/A
Recruiting
Led By Donald Neff
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights
Study Summary
To evaluate postoperative outcomes of BPH/Lower urinary tract symptoms, erectile function, and ejaculatory capacity of simultaneous UroLiftTM and Holmium laser enucleation of the prostatic median lobe.
Eligible Conditions
- Enlarged Prostate
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
International Prostate Symptom Score (IPSS) change (improvement) from baseline at 3 and 12 months.
Secondary outcome measures
Post-Operative measurement of Peak Urine Flow Rate (Qmax)
Post-Operative measurement of Post Void Residual (PVR)
Post-operative participant reported outcomes using International Index of Erectile Function (IIEF).
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Simultaneous UroLift™ and HoLEPExperimental Treatment1 Intervention
UroLift System
Find a Location
Who is running the clinical trial?
University of Kansas Medical CenterLead Sponsor
469 Previous Clinical Trials
171,322 Total Patients Enrolled
Donald NeffPrincipal InvestigatorUniversity of Kansas Medical Center
1 Previous Clinical Trials
10 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger